Medipharm Labs Corp T.LABS

Generic production.

[alleyesonme]

Medipharm has stated multiple times including the most recent PR "opportunities in generic drugs". The CBD FDA masterfile once approved will provide the opportunity to re-label CBD 100 and sell as an generic alternative to epidiolex....the patent is weak because the API is natural hence unpatentable..yes GW has a patent but it's for something other than the API...the substance which helps the ailment is pharma-grade CBD...which other company is anywhere near this stage?? None.....Epidiolex is the only cannabinoid FDA approved drug!....when they say they are looking at generics they are saying Epidiolex...this is going to be HUGE.. Over the head of the market...medipharm is trading at cash on hand...WTF....opportunity??? Major....insiders arnt buying because they are sitting on major news....once the news comes out this stock will hammer...then they will use warrents obtained in the last PP to acquire...institutional investment will pile one once our market cap is much higher....medipharm is too low to meet criteria for institutions...much like they piled on in the 2-7$ range..they will be back....IMHO

[alleyesonme]

1...100ml bottle of epidiolex..100mg CBD per 1ml..(same as CBD 100 from medipharm) costs 1700-2200$ usd..covered by insurers....I paid 80$ for a 30ml bottle of CBD100...what's the difference between products???trace amounts of non pharma ingredients in epidiolex..

[edvirtual]

This post has been removed in accordance with Community Policy

[subaru1]

I wish you are right, i will be almost millionnaire..if it happens.